ClinicalTrials.gg
Drug

Fimasartan clinical trials

Includes 2 studies of Fimasartan potassium trihydrate.

studies test it
50
open now
1
in phase 3
13
first study started
2003

How each study uses fimasartan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the fimasartan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Fimasartan
32
Kanarb
8
Fimasartan 120mg
2

Development codes

BR1017A
1
BR1015-1
1

In one entry with another drug

Given together, or one or the other

Fimasartan/Amlodipine
3

Studies by the year they started

50 studies that test it; most in 2009 (7)

Studies that test fimasartan, by start year
YearStudies
20031
20041
20071
20082
20097
20104
20111
20126
20133
20147
20156
20163
20172
20182
20191
20211
20221
20231

By phase

A phase 1/2 study counts in both.

Phase 1
23
Phase 2
4
Phase 3
13
Phase 4
9
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 42 · Other 8

Boryung Pharmaceutical Co., Ltd (40) · Seoul National University Hospital (2) · R-Pharm (1) · Asan Medical Center (1) · Stendhal Americas, S.A. (1) · Seoul National University Bundang Hospital (1) · Seung-Jung Park (1) · Centro Universitario de Ciencias de la Salud, Mexico (1)

Often tested with

Tested in the same studies.

Amlodipine (9) · Rosuvastatin (7) · Atorvastatin (6) · Hydrochlorothiazide (3) · Indapamide (2) · Ezetimibe (1) · Candesartan cilexetil (1) · Candesartan (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses fimasartan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 50

See all 50 studies that test fimasartan →

As the comparator · 7 — what is tested is compared with fimasartan

Codes

What other systems call fimasartan · ClinicalTrials.gg INT005848

  • MeSH (NLM) C558933fimasartanOne source NLM
  • UNII (FDA) P58222188PFIMASARTANConfirmed FDA, NLM, Wikidata
  • Wikidata Q8563179fimasartanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C81417FimasartanOne source FDA
  • DrugBank DB09279One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.